1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Airway Remodeling in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Airway Remodeling: The structural changes in the number, mass, size and/or composition of the airway tissues.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ziino, AJ | 1 |
Ivanovska, J | 1 |
Belcastro, R | 1 |
Kantores, C | 1 |
Xu, EZ | 1 |
Lau, M | 1 |
McNamara, PJ | 1 |
Tanswell, AK | 1 |
Jankov, RP | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Airway Remodeling
Article | Year |
---|---|
Effects of rho-kinase inhibition on pulmonary hypertension, lung growth, and structure in neonatal rats chronically exposed to hypoxia.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Airway Remodeling; Amides; Animals; Animals, Newborn; | 2010 |